The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Robb Gary Charles since 2017.
This trader's CIK number is 1529655.
At the time of last reporting, Robb Gary Charles was the Chief Business Officer of Corcept Therapeutics Inc. (stock ticker symbol CORT).
Also see all insider trading activities at Corcept Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CORT | 0 | $0 | 5,511 | $391,176 | 5,000 | $19,400 |
| 2024 | CORT | 0 | $0 | 27,710 | $1,100,731 | 36,000 | $118,440 |
| 2023 | CORT | 0 | $0 | 56,593 | $1,420,818 | 133,963 | $368,813 |
| 2022 | CORT | 0 | $0 | 170,901 | $4,210,758 | 200,000 | $415,999 |
| 2021 | CORT | 0 | $0 | 180,500 | $4,635,303 | 600,000 | $1,619,999 |
| 2019 | CORT | 0 | $0 | 30,000 | $412,020 | 30,000 | $57,600 |
| 2018 | CORT | 0 | $0 | 25,000 | $475,150 | 25,000 | $48,000 |
| 2017 | CORT | 5,600 | $54,588 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-22 | CORT | Sale | 2,326 | 71.27 | 165,774 |
| 2025-08-22 | CORT | Option Ex | 5,000 | 3.88 | 19,400 |
| 2025-06-16 | CORT | Sale | 3,185 | 70.77 | 225,402 |
| 2024-11-22 | CORT | Sale | 2,609 | 56.20 | 146,625 |
| 2024-10-01 | CORT | Option Ex | 11,000 | 3.29 | 36,190 |
| 2024-10-01 | CORT | Sale | 11,000 | 46.28 | 509,080 |
| 2024-08-26 | CORT | Sale | 3,101 | 35.71 | 110,736 |
| 2024-06-04 | CORT | Option Ex | 14,000 | 3.29 | 46,060 |
| 2024-05-28 | CORT | Option Ex | 11,000 | 3.29 | 36,190 |
| 2024-05-28 | CORT | Sale | 11,000 | 30.39 | 334,290 |
| 2023-12-04 | CORT | Option Ex | 15,000 | 3.29 | 49,350 |
| 2023-12-06 | CORT | Sale | 6,212 | 27.01 | 167,786 |
| 2023-12-05 | CORT | Sale | 1,381 | 26.27 | 36,277 |
| 2023-09-19 | CORT | Sale | 5,000 | 32.73 | 163,675 |
| 2023-09-14 | CORT | Option Ex | 13,963 | 3.29 | 45,938 |
| 2023-05-10 | CORT | Sale | 14,000 | 24.07 | 336,980 |
| 2023-05-09 | CORT | Sale | 30,000 | 23.87 | 716,100 |
| 2023-05-05 | CORT | Option Ex | 105,000 | 2.60 | 273,525 |
| 2022-11-22 | CORT | Sale | 4,814 | 26.03 | 125,308 |
| 2022-11-23 | CORT | Sale | 186 | 26.03 | 4,841 |
| 2022-11-17 | CORT | Sale | 10,000 | 26.06 | 260,600 |
| 2022-11-18 | CORT | Sale | 13,401 | 26.43 | 354,188 |
| 2022-09-07 | CORT | Sale | 50,000 | 26.06 | 1,303,000 |
| 2022-08-30 | CORT | Option Ex | 167,323 | 2.08 | 348,031 |
| 2022-07-06 | CORT | Option Ex | 32,677 | 2.08 | 67,968 |
| 2022-07-06 | CORT | Sale | 45,000 | 26.00 | 1,170,000 |
| 2022-05-18 | CORT | Sale | 128 | 19.55 | 2,502 |
| 2022-05-19 | CORT | Sale | 6,127 | 19.57 | 119,929 |
| 2022-05-17 | CORT | Sale | 28,745 | 19.55 | 561,964 |
| 2022-03-17 | CORT | Sale | 7,512 | 24.68 | 185,373 |
| 2022-03-18 | CORT | Sale | 4,988 | 24.67 | 123,053 |
| 2021-09-15 | CORT | Sale | 47,853 | 20.50 | 980,747 |
| 2021-09-14 | CORT | Sale | 806 | 20.76 | 16,735 |
| 2021-09-13 | CORT | Sale | 6,341 | 20.89 | 132,444 |
| 2021-08-30 | CORT | Option Ex | 148,148 | 2.70 | 399,999 |
| 2021-04-23 | CORT | Sale | 10,000 | 24.02 | 240,219 |
| 2021-02-11 | CORT | Sale | 3,400 | 29.78 | 101,248 |
| 2021-02-12 | CORT | Sale | 112,100 | 28.22 | 3,163,910 |
| 2021-01-22 | CORT | Option Ex | 451,852 | 2.70 | 1,220,000 |
| 2019-12-09 | CORT | Sale | 30,000 | 13.73 | 412,020 |
| 2019-12-09 | CORT | Option Ex | 30,000 | 1.92 | 57,600 |
| 2018-12-12 | CORT | Option Ex | 25,000 | 1.92 | 48,000 |
| 2018-12-12 | CORT | Sale | 25,000 | 19.01 | 475,150 |
| 2017-05-04 | CORT | Buy | 5,600 | 9.75 | 54,588 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Robb Gary Charles (Chief Business Officer of Corcept Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.